Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Multicenter International Study on Prognostic Factors, Management And Outcome Of Primary Mediastinal Large B-Cell Lymphoma (PMLBCL) Patients With Central Nervous System (CNS) Involvement

NCT06024694 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT06024694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06024694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Multicenter International Study on Prognostic Factors, Management And Outcome Of Primary Mediastinal Large B-Cell Lymphoma (PMLBCL) Patients With Central Nervous System (CNS) Involvement
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Active, not recruiting
Start date
June 30, 2022
Completion date
June 10, 2027
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary mediastinal large b-cell lymphoma (pmbcl)